ENDPOINTS

Zealand partners with Roche on petrelintide in a deal worth $5.3B

Zealand Pharma has finally found a partner. Zealand said Wednesday it will be working with Roche on its lead obesity candidate petrelintide, with the Swiss pharma paying $1.65 billion upfront in ...

Mar 12, 2025 - 09:11
 0
Zealand partners with Roche on petrelintide in a deal worth $5.3B
Zealand Pharma has finally found a partner. Zealand said Wednesday it will be working with Roche on its lead obesity candidate petrelintide, with the Swiss pharma paying $1.65 billion upfront in ...
Read More

Tags:

Previous Article

Prison Boss Prohibition Has A Mixed Reality Mode With Online And Couch Co-Op

Next Article

SpaceX craft to launch to retrieve 2 astronauts who have been swept up in politics

Related Posts

Moderna stands by its Covid vaccine patents after PTAB decision

Moderna stands by its Covid vaccine patents after PTAB ...

Mar 6, 2025  0

How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruition

How Bain’s $3.3B deal for a centuries-old Japanese phar...

Feb 14, 2025  0

China to ban Illumina's DNA sequencers following US tariffs

China to ban Illumina's DNA sequencers following US tar...

Mar 4, 2025  0